| Melissa Forbes, CNM | |
|
299 Saint Michaels Cir, Odenton, MD 21113-1093 | |
| (347) 701-9829 | |
| Not Available |
| Full Name | Melissa Forbes |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 299 Saint Michaels Cir, Odenton, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861026726 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | (* (Not Available)) | Primary |
| Entity Name | Dimensions Healthcare Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346354834 PECOS PAC ID: 1557269743 Enrollment ID: O20031226000032 |
News Archive
The Washington Post: "An appeals court ruled Thursday that the federal government can resume funding human embryonic stem cell research while the court reviews a judge's order that had temporarily prohibited such funding. A three-judge panel of the U.S. Court of Appeals for the D.C. Circuit granted a request from the Justice Department to lift a temporary injunction issued Aug. 23 blocking the funding on the grounds that it violated a law barring funding any research that involves the destruction of human embryos.
Researchers from the University of Exeter in England have found that cancer patients are being mislead by many popular health web sites providing bogus information to peddle alternative medicinal treatments.
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the U.S. Food & Drug Administration (FDA) has granted fast track designation for the company's critical limb ischemia (CLI) cell therapy development program. Aastrom plans to initiate Phase 3 clinical testing of its treatment for CLI in early 2011.
Robots and artificial intelligence are being deployed across the globe in the fight against the coronavirus pandemic.
A new study of brain activity in depressed and anxious people indicates that some of the ill effects of depression are modified - for better or for worse - by anxiety
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Forbes, CNM 299 Saint Michaels Cir, Odenton, MD 21113-1093 Ph: () - | Melissa Forbes, CNM 299 Saint Michaels Cir, Odenton, MD 21113-1093 Ph: (347) 701-9829 |
News Archive
The Washington Post: "An appeals court ruled Thursday that the federal government can resume funding human embryonic stem cell research while the court reviews a judge's order that had temporarily prohibited such funding. A three-judge panel of the U.S. Court of Appeals for the D.C. Circuit granted a request from the Justice Department to lift a temporary injunction issued Aug. 23 blocking the funding on the grounds that it violated a law barring funding any research that involves the destruction of human embryos.
Researchers from the University of Exeter in England have found that cancer patients are being mislead by many popular health web sites providing bogus information to peddle alternative medicinal treatments.
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the U.S. Food & Drug Administration (FDA) has granted fast track designation for the company's critical limb ischemia (CLI) cell therapy development program. Aastrom plans to initiate Phase 3 clinical testing of its treatment for CLI in early 2011.
Robots and artificial intelligence are being deployed across the globe in the fight against the coronavirus pandemic.
A new study of brain activity in depressed and anxious people indicates that some of the ill effects of depression are modified - for better or for worse - by anxiety
› Verified 4 days ago